Lowering The Lipid Barrier: Enabling Any Scientist To Be A Genomic Medicine Developer
Source: Precision NanoSystems
![LNP Formulations Feature LNP Formulations Feature](https://vertassets.blob.core.windows.net/image/3d361823/3d361823-3d7b-4216-a604-939ae18251d7/375_250-lnp_formulations_feature.jpg)
Nanomedicine is a promising treatment strategy to target a range of diseases with limited side effects and complications. Although RNA (ribonucleic acid) molecules are fragile and can degrade quickly, new non-viral gene delivery approaches, such as nanoparticles, have the potential to deliver a range of RNA-based therapeutics and vaccines effectively. Learn how you can fast-track RNA-LNP development and streamline screening with off-the-shelf ionizable lipid mixes as well as utilize these validation strategies using ready-made formulations to generate reproducible and scalable LNPs for lead candidates.
access the Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.
Subscribe to Cell & Gene
X
Subscribe to Cell & Gene
Precision NanoSystems
This website uses cookies to ensure you get the best experience on our website. Learn more